Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Bone Marrow Transplantation|December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMTGwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
European Journal of Haematology|January 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics SequencingRafael Hernani, Eliseo Albert, Carlos Hernani-Morales, et al.
Ejhaem|March 20, 2025
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T TherapyRafael Hernani, Laura Ventura, Begoña Heras, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Frontiers in Microbiology|August 30, 2016
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisCarmen B Lupiañez, María T Villaescusa, Agostinho Carvalho, et al.
Blood Advances|May 29, 2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMTJuan Montoro, Maud Ngoya, Alexander Kulagin, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Bone Marrow Transplantation|December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMTGwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
European Journal of Haematology|January 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics SequencingRafael Hernani, Eliseo Albert, Carlos Hernani-Morales, et al.
Ejhaem|March 20, 2025
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T TherapyRafael Hernani, Laura Ventura, Begoña Heras, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Bone Marrow Transplantation|February 22, 2023
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyRaffaella Greco, Jorinde D Hoogenboom, Edouard F Bonneville, et al.
Frontiers in Microbiology|August 30, 2016
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisCarmen B Lupiañez, María T Villaescusa, Agostinho Carvalho, et al.
Blood Advances|May 29, 2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMTJuan Montoro, Maud Ngoya, Alexander Kulagin, et al.
Pageof 28